Administration of drug in form of liquid, semisolid and solid formulation through nasal route is termed as nasal drug delivery mode. It is used as a form of treatment of infection in the paranasal sinuses such as allergic & non-allergic sinusitis & rhinitis.
Global Nasal Drug Delivery Mode Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Nasal Drug Delivery Mode market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
Market Segmentation
According to MarkNtel Advisors’ research report titled “Global Nasal Drug Delivery Mode Market Analysis, 2020”, the Global Nasal Drug Delivery Mode market is anticipated to grow at a CAGR of around 6.4% during 2020-25F. Based on dosage form, the spray segment acquired the majority market share in 2019 due to a significant rise in the number of patients suffering from chronic rhinitis which further leads to swelling, congestion, irritation in the nasal mucosa, and runny nose. Moreover, the introduction of new products in the nasal spray domain for easy administration, rising adoption of self-administration practices, and growing awareness about nasal sprays and their benefits are expected to fuel the demand for nasal sprays which are also actively used for shrinking blood vessels in the nose.
Homecare Setting Acquired Significant Market Share
Based on end-user, homecare setting acquired the largest market share in 2019. The growth is attributed to the rising inclination of patients toward self-administration practices of drugs, the burgeoning number of patients suffering from rhinitis and the escalating usage of nasal powders and sprays which not only saves time and money but also reduces healthcare costs incurred by the patient. Therefore, this is anticipated to strongly contribute toward the growth of the Nasal Drug Delivery Mode market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Nasal Drug Delivery Mode Market Analysis, 2020”.
Market Opportunities
The factors driving the growth of the market are rising number of product approvals, launch of environment-friendly inhalers for Chronic Obstructive Pulmonary Disease (COPD) and asthma patients, rising consumption of tobacco, and air pollution. In addition, escalating investment in the research and development activities, burgeoning practices of self-administration, growing popularity of inhalers in developed and developing countries along with boost in the number of people suffering from asthma and rhinitis are expected to promulgate the growth of Nasal Drug Delivery Mode market.
Competitive Landscape
According to MarkNtel Advisors, the key players with a considerable market share in the Global Nasal Drug Delivery Mode market include Merck & Co., Inc., GlaxoSmithKline Plc, AstraZeneca, Johnson & Johnson Services Inc., Mystic Pharmaceuticals, Bausch Health, BD, 3M, AptarGroup, Inc., OptiNose US, Inc., Dr. Reddy’s Laboratories Ltd., Flo Nasal Products, Cadila Pharmaceuticals, PendoPharm Inc, Neurelis, Inc.
Key Questions Answered in the Market Research Report:
Market Outlook, Segmentation and Statistics
Frequently Asked Questions:
Q. What is the historical year, base year and forecast year considered in the research report on Global Nasal Drug Delivery Mode Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.
Q. What would be the growth rate or CAGR of Global Nasal Drug Delivery Mode Market during 2020-25?
A. The growth rate of Global Nasal Drug Delivery Mode Market during 2020-25 is forecast to be grow at a CAGR of 6.4%
Q. Who are the key competitors or players operating in Global Nasal Drug Delivery Mode Market?
A. Merck & Co., Inc., GlaxoSmithKline Plc, AstraZeneca, Johnson & Johnson Services Inc., Mystic Pharmaceuticals, Bausch Health, BD, 3M, AptarGroup, Inc., OptiNose US, Inc., Dr. Reddy’s Laboratories Ltd., Flo Nasal Products, Cadila Pharmaceuticals, PendoPharm Inc, Neurelis, Inc., are few of the leading players in the Global Nasal Drug Delivery Mode Market.
Q. Which therapeutic application segment would emerge as an opportunity area for players in Global Nasal Drug Delivery Mode Market?
A. Asthma is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Nasal Drug Delivery Mode Market?
A. Asia-Pacific grabbed a significant market share continue to grow at a highest CAGR, presenting immense opportunities for market players of Global Nasal Drug Delivery Mode Market.
